292 Index
anthrax 264
antibiotics 269–70
antisnake venom vaccines 271
anxiety‐related behavior 207–8
apoptosis 208, 235–6
Arabidopsis thaliana 74
arginine vasopressin (AVP) 36–7, 76
neurons producing 103f
arginine vasopressin receptor
(AVPR) 29, 40, 235
AVPR1α and/or AVPR1β 106
Armani, Giorgio: Acqua Di Gio 178
aromatase enzyme 130, 132, 133
arsenic 170, 177t
artificial vanilla 4
ascabin see benzyl benzoate
ascabiol see benzyl benzoate
Asperger, Hans 23, 53–5, 56
Asperger syndrome 20, 39, 40, 53, 54,
61, 63, 67
brain size 41
male gender bias in 9, 40
assisted reproductive technologies 170
atrazine 173t
attention‐deficit/hyperactivity disorder
(ADHD) 67, 68
atypical autism see regressive autism
autism spectrum disorder (ASD) 55f
definition 62
diagnosis of 51, 12
genesis 158–9
persistent deficits 61, 62–3
“spectrum” 20–2, 39–41, 155f
severity 67–8
with and without intellectual
disability 69–70
autistic disorder 63, 64
autoimmune hemolytic anemia 249
autoimmune hypothetical model 240f
autoimmune orchitis 239
autoimmunity 241, 248–9
avian flu 2
AZT 26b
Bacteroides fragilis 9
bad mothering 67, 146
Baur, Albert 4, 186
bed nucleus of the stria terminalis
(BNST) 206
benzene hexachloride 172t
benzene ring products 29
benzo[a]pyrene 176t
benzophenone 176t
benzophenone‐1 13, 37, 76, 131,
170, 171
benzophenone‐2 13, 37, 76, 131,
170, 171
benzyl benzoate 13, 37, 76, 100, 131,
170, 186, 194, 223
chemical structure and adverse
effects of 187t
benzyl salicylate 13, 37, 76, 100, 131,
170, 186, 194, 223
chemical structure and adverse
effects of 187t
Bettelheim, Bruno 53, 57, 169
birth rates, global 220f
bisphenol A (BPA) 151, 176t, 196,
217–18, 252
bisphenol F 176t
bisphenol S (BPS) 218
blood–brain barrier (BBB) 42, 254–6,
274–5
‘leaky’ 42, 250, 254, 275–8, 276f, 279
normal 276f
brain
areas that process olfactory data 84
ASD genesis ans 31–2
areas affected by neuromodifying
agents during fetal
development 29f
development 15, 17, 22f, 32–4, 33f,
36–9, 99
gender and 132–4
human, vs mouse 72
human, vs nonhuman primate 35